0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Microbial Antimicrobial Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-13M10338
Home | Market Reports | Science
Global Microbial Antimicrobial Peptides Market Insights Forecast to 2028
BUY CHAPTERS

Microbial Antimicrobial Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13M10338
Report
October 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Microbial Antimicrobial Peptides - Market Size

The global market for Microbial Antimicrobial Peptides was estimated to be worth US$ 2 million in 2023 and is forecast to a readjusted size of US$ 3 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030

Microbial Antimicrobial Peptides - Market

Microbial Antimicrobial Peptides - Market

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Microbial Antimicrobial Peptides, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Microbial Antimicrobial Peptides by region & country, by Type, and by Application.
The Microbial Antimicrobial Peptides market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Antimicrobial Peptides.
Market Segmentation

Scope of Microbial Antimicrobial Peptides - Market Report

Report Metric Details
Report Name Microbial Antimicrobial Peptides - Market
Forecasted market size in 2030 US$ 3 million
CAGR 5.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Bacteria
  • Fungi
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Microbial Antimicrobial Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Microbial Antimicrobial Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Microbial Antimicrobial Peptides in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Microbial Antimicrobial Peptides - Market size in 2030?

Ans: The Microbial Antimicrobial Peptides - Market size in 2030 will be US$ 3 million.

What is the AnaSpec share in Microbial Antimicrobial Peptides - Market?

Ans: The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

What is the Microbial Antimicrobial Peptides - Market share by region?

Ans: By region, North America had the highest share of sales, at about 35%.

Who are the main players in the Microbial Antimicrobial Peptides - Market report?

Ans: The main players in the Microbial Antimicrobial Peptides - Market are AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores

What are the Application segmentation covered in the Microbial Antimicrobial Peptides - Market report?

Ans: The Applications covered in the Microbial Antimicrobial Peptides - Market report are Pharmaceuticals, Feed Additives, Others

What are the Type segmentation covered in the Microbial Antimicrobial Peptides - Market report?

Ans: The Types covered in the Microbial Antimicrobial Peptides - Market report are Bacteria, Fungi

Recommended Reports

Antimicrobial Peptides

Antimicrobial Therapeutics

Microbial and Antiviral

1 Market Overview
1.1 Microbial Antimicrobial Peptides Product Introduction
1.2 Global Microbial Antimicrobial Peptides Market Size Forecast
1.2.1 Global Microbial Antimicrobial Peptides Sales Value (2019-2030)
1.2.2 Global Microbial Antimicrobial Peptides Sales Volume (2019-2030)
1.2.3 Global Microbial Antimicrobial Peptides Sales Price (2019-2030)
1.3 Microbial Antimicrobial Peptides Market Trends & Drivers
1.3.1 Microbial Antimicrobial Peptides Industry Trends
1.3.2 Microbial Antimicrobial Peptides Market Drivers & Opportunity
1.3.3 Microbial Antimicrobial Peptides Market Challenges
1.3.4 Microbial Antimicrobial Peptides Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Microbial Antimicrobial Peptides Players Revenue Ranking (2023)
2.2 Global Microbial Antimicrobial Peptides Revenue by Company (2019-2024)
2.3 Global Microbial Antimicrobial Peptides Players Sales Volume Ranking (2023)
2.4 Global Microbial Antimicrobial Peptides Sales Volume by Company Players (2019-2024)
2.5 Global Microbial Antimicrobial Peptides Average Price by Company (2019-2024)
2.6 Key Manufacturers Microbial Antimicrobial Peptides Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Microbial Antimicrobial Peptides Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Microbial Antimicrobial Peptides
2.9 Microbial Antimicrobial Peptides Market Competitive Analysis
2.9.1 Microbial Antimicrobial Peptides Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Microbial Antimicrobial Peptides Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial Antimicrobial Peptides as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bacteria
3.1.2 Fungi
3.2 Global Microbial Antimicrobial Peptides Sales Value by Type
3.2.1 Global Microbial Antimicrobial Peptides Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Microbial Antimicrobial Peptides Sales Value, by Type (2019-2030)
3.2.3 Global Microbial Antimicrobial Peptides Sales Value, by Type (%) (2019-2030)
3.3 Global Microbial Antimicrobial Peptides Sales Volume by Type
3.3.1 Global Microbial Antimicrobial Peptides Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Microbial Antimicrobial Peptides Sales Volume, by Type (2019-2030)
3.3.3 Global Microbial Antimicrobial Peptides Sales Volume, by Type (%) (2019-2030)
3.4 Global Microbial Antimicrobial Peptides Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceuticals
4.1.2 Feed Additives
4.1.3 Others
4.2 Global Microbial Antimicrobial Peptides Sales Value by Application
4.2.1 Global Microbial Antimicrobial Peptides Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Microbial Antimicrobial Peptides Sales Value, by Application (2019-2030)
4.2.3 Global Microbial Antimicrobial Peptides Sales Value, by Application (%) (2019-2030)
4.3 Global Microbial Antimicrobial Peptides Sales Volume by Application
4.3.1 Global Microbial Antimicrobial Peptides Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Microbial Antimicrobial Peptides Sales Volume, by Application (2019-2030)
4.3.3 Global Microbial Antimicrobial Peptides Sales Volume, by Application (%) (2019-2030)
4.4 Global Microbial Antimicrobial Peptides Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Microbial Antimicrobial Peptides Sales Value by Region
5.1.1 Global Microbial Antimicrobial Peptides Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Microbial Antimicrobial Peptides Sales Value by Region (2019-2024)
5.1.3 Global Microbial Antimicrobial Peptides Sales Value by Region (2025-2030)
5.1.4 Global Microbial Antimicrobial Peptides Sales Value by Region (%), (2019-2030)
5.2 Global Microbial Antimicrobial Peptides Sales Volume by Region
5.2.1 Global Microbial Antimicrobial Peptides Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Microbial Antimicrobial Peptides Sales Volume by Region (2019-2024)
5.2.3 Global Microbial Antimicrobial Peptides Sales Volume by Region (2025-2030)
5.2.4 Global Microbial Antimicrobial Peptides Sales Volume by Region (%), (2019-2030)
5.3 Global Microbial Antimicrobial Peptides Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Microbial Antimicrobial Peptides Sales Value, 2019-2030
5.4.2 North America Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Microbial Antimicrobial Peptides Sales Value, 2019-2030
5.5.2 Europe Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Microbial Antimicrobial Peptides Sales Value, 2019-2030
5.6.2 Asia Pacific Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Microbial Antimicrobial Peptides Sales Value, 2019-2030
5.7.2 South America Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Microbial Antimicrobial Peptides Sales Value, 2019-2030
5.8.2 Middle East & Africa Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Microbial Antimicrobial Peptides Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Microbial Antimicrobial Peptides Sales Value
6.2.1 Key Countries/Regions Microbial Antimicrobial Peptides Sales Value, 2019-2030
6.2.2 Key Countries/Regions Microbial Antimicrobial Peptides Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Microbial Antimicrobial Peptides Sales Value, 2019-2030
6.3.2 United States Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Microbial Antimicrobial Peptides Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Microbial Antimicrobial Peptides Sales Value, 2019-2030
6.4.2 Europe Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Microbial Antimicrobial Peptides Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Microbial Antimicrobial Peptides Sales Value, 2019-2030
6.5.2 China Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
6.5.3 China Microbial Antimicrobial Peptides Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Microbial Antimicrobial Peptides Sales Value, 2019-2030
6.6.2 Japan Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Microbial Antimicrobial Peptides Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Microbial Antimicrobial Peptides Sales Value, 2019-2030
6.7.2 South Korea Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Microbial Antimicrobial Peptides Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Microbial Antimicrobial Peptides Sales Value, 2019-2030
6.8.2 Southeast Asia Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Microbial Antimicrobial Peptides Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Microbial Antimicrobial Peptides Sales Value, 2019-2030
6.9.2 India Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
6.9.3 India Microbial Antimicrobial Peptides Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AnaSpec
7.1.1 AnaSpec Company Information
7.1.2 AnaSpec Introduction and Business Overview
7.1.3 AnaSpec Microbial Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AnaSpec Microbial Antimicrobial Peptides Product Offerings
7.1.5 AnaSpec Recent Development
7.2 AMP Biotech
7.2.1 AMP Biotech Company Information
7.2.2 AMP Biotech Introduction and Business Overview
7.2.3 AMP Biotech Microbial Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AMP Biotech Microbial Antimicrobial Peptides Product Offerings
7.2.5 AMP Biotech Recent Development
7.3 Phoenix Biotech
7.3.1 Phoenix Biotech Company Information
7.3.2 Phoenix Biotech Introduction and Business Overview
7.3.3 Phoenix Biotech Microbial Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Phoenix Biotech Microbial Antimicrobial Peptides Product Offerings
7.3.5 Phoenix Biotech Recent Development
7.4 Novabiotics
7.4.1 Novabiotics Company Information
7.4.2 Novabiotics Introduction and Business Overview
7.4.3 Novabiotics Microbial Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Novabiotics Microbial Antimicrobial Peptides Product Offerings
7.4.5 Novabiotics Recent Development
7.5 Chinese Peptide
7.5.1 Chinese Peptide Company Information
7.5.2 Chinese Peptide Introduction and Business Overview
7.5.3 Chinese Peptide Microbial Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Chinese Peptide Microbial Antimicrobial Peptides Product Offerings
7.5.5 Chinese Peptide Recent Development
7.6 Ontores
7.6.1 Ontores Company Information
7.6.2 Ontores Introduction and Business Overview
7.6.3 Ontores Microbial Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ontores Microbial Antimicrobial Peptides Product Offerings
7.6.5 Ontores Recent Development
8 Industry Chain Analysis
8.1 Microbial Antimicrobial Peptides Industrial Chain
8.2 Microbial Antimicrobial Peptides Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Microbial Antimicrobial Peptides Sales Model
8.5.2 Sales Channel
8.5.3 Microbial Antimicrobial Peptides Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Microbial Antimicrobial Peptides Market Trends
    Table 2. Microbial Antimicrobial Peptides Market Drivers & Opportunity
    Table 3. Microbial Antimicrobial Peptides Market Challenges
    Table 4. Microbial Antimicrobial Peptides Market Restraints
    Table 5. Global Microbial Antimicrobial Peptides Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Microbial Antimicrobial Peptides Revenue Market Share by Company (2019-2024)
    Table 7. Global Microbial Antimicrobial Peptides Sales Volume by Company (2019-2024) & (Kiloton)
    Table 8. Global Microbial Antimicrobial Peptides Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Microbial Antimicrobial Peptides Price by Company (2019-2024) & (US$/Ton)
    Table 10. Key Manufacturers Microbial Antimicrobial Peptides Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Microbial Antimicrobial Peptides Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Microbial Antimicrobial Peptides
    Table 13. Global Microbial Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial Antimicrobial Peptides as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Microbial Antimicrobial Peptides Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Microbial Antimicrobial Peptides Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Microbial Antimicrobial Peptides Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Microbial Antimicrobial Peptides Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Microbial Antimicrobial Peptides Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Microbial Antimicrobial Peptides Sales Volume by Type: 2019 VS 2023 VS 2030 (Kiloton)
    Table 22. Global Microbial Antimicrobial Peptides Sales Volume by Type (2019-2024) & (Kiloton)
    Table 23. Global Microbial Antimicrobial Peptides Sales Volume by Type (2025-2030) & (Kiloton)
    Table 24. Global Microbial Antimicrobial Peptides Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Microbial Antimicrobial Peptides Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Microbial Antimicrobial Peptides Price by Type (2019-2024) & (US$/Ton)
    Table 27. Global Microbial Antimicrobial Peptides Price by Type (2025-2030) & (US$/Ton)
    Table 28. Global Microbial Antimicrobial Peptides Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Microbial Antimicrobial Peptides Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Microbial Antimicrobial Peptides Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Microbial Antimicrobial Peptides Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Microbial Antimicrobial Peptides Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Microbial Antimicrobial Peptides Sales Volume by Application: 2019 VS 2023 VS 2030 (Kiloton)
    Table 34. Global Microbial Antimicrobial Peptides Sales Volume by Application (2019-2024) & (Kiloton)
    Table 35. Global Microbial Antimicrobial Peptides Sales Volume by Application (2025-2030) & (Kiloton)
    Table 36. Global Microbial Antimicrobial Peptides Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Microbial Antimicrobial Peptides Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Microbial Antimicrobial Peptides Price by Application (2019-2024) & (US$/Ton)
    Table 39. Global Microbial Antimicrobial Peptides Price by Application (2025-2030) & (US$/Ton)
    Table 40. Global Microbial Antimicrobial Peptides Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Microbial Antimicrobial Peptides Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Microbial Antimicrobial Peptides Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Microbial Antimicrobial Peptides Sales Value by Region (2019-2024) & (%)
    Table 44. Global Microbial Antimicrobial Peptides Sales Value by Region (2025-2030) & (%)
    Table 45. Global Microbial Antimicrobial Peptides Sales Volume by Region (Kiloton): 2019 VS 2023 VS 2030
    Table 46. Global Microbial Antimicrobial Peptides Sales Volume by Region (2019-2024) & (Kiloton)
    Table 47. Global Microbial Antimicrobial Peptides Sales Volume by Region (2025-2030) & (Kiloton)
    Table 48. Global Microbial Antimicrobial Peptides Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Microbial Antimicrobial Peptides Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Microbial Antimicrobial Peptides Average Price by Region (2019-2024) & (US$/Ton)
    Table 51. Global Microbial Antimicrobial Peptides Average Price by Region (2025-2030) & (US$/Ton)
    Table 52. Key Countries/Regions Microbial Antimicrobial Peptides Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Microbial Antimicrobial Peptides Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Microbial Antimicrobial Peptides Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Microbial Antimicrobial Peptides Sales Volume, (2019-2024) & (Kiloton)
    Table 56. Key Countries/Regions Microbial Antimicrobial Peptides Sales Volume, (2025-2030) & (Kiloton)
    Table 57. AnaSpec Company Information
    Table 58. AnaSpec Introduction and Business Overview
    Table 59. AnaSpec Microbial Antimicrobial Peptides Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 60. AnaSpec Microbial Antimicrobial Peptides Product Offerings
    Table 61. AnaSpec Recent Development
    Table 62. AMP Biotech Company Information
    Table 63. AMP Biotech Introduction and Business Overview
    Table 64. AMP Biotech Microbial Antimicrobial Peptides Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 65. AMP Biotech Microbial Antimicrobial Peptides Product Offerings
    Table 66. AMP Biotech Recent Development
    Table 67. Phoenix Biotech Company Information
    Table 68. Phoenix Biotech Introduction and Business Overview
    Table 69. Phoenix Biotech Microbial Antimicrobial Peptides Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 70. Phoenix Biotech Microbial Antimicrobial Peptides Product Offerings
    Table 71. Phoenix Biotech Recent Development
    Table 72. Novabiotics Company Information
    Table 73. Novabiotics Introduction and Business Overview
    Table 74. Novabiotics Microbial Antimicrobial Peptides Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 75. Novabiotics Microbial Antimicrobial Peptides Product Offerings
    Table 76. Novabiotics Recent Development
    Table 77. Chinese Peptide Company Information
    Table 78. Chinese Peptide Introduction and Business Overview
    Table 79. Chinese Peptide Microbial Antimicrobial Peptides Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 80. Chinese Peptide Microbial Antimicrobial Peptides Product Offerings
    Table 81. Chinese Peptide Recent Development
    Table 82. Ontores Company Information
    Table 83. Ontores Introduction and Business Overview
    Table 84. Ontores Microbial Antimicrobial Peptides Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 85. Ontores Microbial Antimicrobial Peptides Product Offerings
    Table 86. Ontores Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Microbial Antimicrobial Peptides Downstream Customers
    Table 90. Microbial Antimicrobial Peptides Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Microbial Antimicrobial Peptides Product Picture
    Figure 2. Global Microbial Antimicrobial Peptides Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Microbial Antimicrobial Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Microbial Antimicrobial Peptides Sales Volume (2019-2030) & (Kiloton)
    Figure 5. Global Microbial Antimicrobial Peptides Sales Price (2019-2030) & (US$/Ton)
    Figure 6. Microbial Antimicrobial Peptides Report Years Considered
    Figure 7. Global Microbial Antimicrobial Peptides Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Microbial Antimicrobial Peptides Players Sales Volume Ranking (2023) & (Kiloton)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Microbial Antimicrobial Peptides Revenue in 2023
    Figure 10. Microbial Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Bacteria Picture
    Figure 12. Fungi Picture
    Figure 13. Global Microbial Antimicrobial Peptides Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Microbial Antimicrobial Peptides Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Microbial Antimicrobial Peptides Sales Volume by Type (2019 VS 2023 VS 2030) & (Kiloton)
    Figure 16. Global Microbial Antimicrobial Peptides Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Microbial Antimicrobial Peptides Price by Type (2019-2030) & (US$/Ton)
    Figure 18. Product Picture of Pharmaceuticals
    Figure 19. Product Picture of Feed Additives
    Figure 20. Product Picture of Others
    Figure 21. Global Microbial Antimicrobial Peptides Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Microbial Antimicrobial Peptides Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Microbial Antimicrobial Peptides Sales Volume by Application (2019 VS 2023 VS 2030) & (Kiloton)
    Figure 24. Global Microbial Antimicrobial Peptides Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Microbial Antimicrobial Peptides Price by Application (2019-2030) & (US$/Ton)
    Figure 26. North America Microbial Antimicrobial Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Microbial Antimicrobial Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Microbial Antimicrobial Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Microbial Antimicrobial Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Microbial Antimicrobial Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Microbial Antimicrobial Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Microbial Antimicrobial Peptides Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Microbial Antimicrobial Peptides Sales Volume (%), (2019-2030)
    Figure 38. United States Microbial Antimicrobial Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Microbial Antimicrobial Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Microbial Antimicrobial Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Microbial Antimicrobial Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Microbial Antimicrobial Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Microbial Antimicrobial Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Microbial Antimicrobial Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Microbial Antimicrobial Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Microbial Antimicrobial Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Microbial Antimicrobial Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Microbial Antimicrobial Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Microbial Antimicrobial Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Microbial Antimicrobial Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Microbial Antimicrobial Peptides Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Microbial Antimicrobial Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 59. Microbial Antimicrobial Peptides Industrial Chain
    Figure 60. Microbial Antimicrobial Peptides Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS